The NADPH oxidase family and its inhibitors

Archivum Immunologiae et Therapiae Experimentalis

Volumn 60, Issue 4, 2012, Pages 277-294

  Kleniewska, Paulina ^a   Piechota, Aleksandra ^a   Skibska, Beata ^a   Gorąca, Anna ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Cardiovascular disease; NADPH oxidase; Nox family; Nox inhibitors; Reactive oxygen species

Indexed keywords

1,4 DIMETHYL 2,3,5,6 TETRAIODOBENZENE; 3 BENZYL 7 (2 BENZOXAZOLYL)THIO 1,2,3 TRIAZOLO[4,5 D]PYRIMIDINE; 4 (2 AMINOETHYL)BENZENESULFONYL FLUORIDE; APOCYNIN; BENZYL ISOTHIOCYANATE; CLOSTRIDIUM DIFFICILE TOXIN B; COMPACTIN; DIPHENYLIODONIUM SALT; ENZYME INHIBITOR; GLIOTOXIN; GP91DS TAT PEPTIDE; LOSARTAN; METFORMIN; MINOCYCLINE; NEBIVOLOL; OXIDOREDUCTASE; PERHEXILINE; PR 39; PROTEIN KINASE C; PROTEIN NOX5; PROTEIN SH3; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; RESVERATROL; ROXITHROMYCIN; S 17834; SILDENAFIL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VAS 2870; VASCULOTROPIN;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HYPERTENSION; MOLECULAR PATHOLOGY; NONHUMAN; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; REVIEW; STRUCTURE ANALYSIS;

EID: 84866490649     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-012-0176-z     Document Type: Review

References (195)

1. Abdelghaffar H, Babin-Chevaye C, Labro MT (2005) The macrolide roxithromyci impairs NADP oxidase activation and alters translocation of its cytosoli components to the neutrophil membrane in vitro. Antimicrob Agents Chemother 49:2986-2989 (Pubitemid 40917622)
2. Agwuh KN, MacGowan A (2006) Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J Antimicrob Chemother 58:256-265 (Pubitemid 44294934)
3. Allison AC, Eugui EM (2000) Mycophenolate mofetil and its mechanisms on action. Immunopharmacology 47:85-118 (Pubitemid 30394534)
4. Anderson R (1989) Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-Activated superoxide generation and autooxidation. J Infect Dis 159:966-973 (Pubitemid 19113085)
5. Ashrafian H, Horowitz JD, Frenneaux MP (2007) Perhexiline. Cardiovasc Drug Rev 25:76-97 (Pubitemid 46625291)
6. Babior BM (1999) NADPH oxidase: An update. Blood 93:1464-1476 (Pubitemid 29102471)
7. Babior BM (2004) NADPH oxidase. Curr Opin Immunol 16:42-47 (Pubitemid 38198116)
8. Babior BM, Kipnes RS, Curnutte JT (1973) Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 52:741-746
9. Bai YP, Hu CP, ChenMF et al (2009) Inhibitory effect of reinioside C on monocyte-endothelial cell adhesion induced by oxidized lowdensity lipoprotein via inhibitingNADPHoxidase/ROS/NF-kappaB pathway. Naunyn Schmiedebergs Arch Pharmacol 380:399-406
10. Banfi B, Clark RA, Steger K et al (2003) Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J Biol Chem 278:3510-3513 (Pubitemid 36801072)
11. Banfi B, Malgrange B, Knisz J et al (2004) NOX3, a superoxidegenerating NADPH oxidase of the inner ear. J Biol Chem 279:46065-46072 (Pubitemid 39491600)
12. BaruaM, LiuY, QuinnMR(2001)Taurine chloramine inhibits inducible nitric oxide synthase and TNF-Alpha gene expression in activated alveolar macromacrophages: decreased NF-kappaB activation and IkappaB kinase activity. J Immunol 167:2275-2281 (Pubitemid 32747540)
13. Bataller R, Schwabe RF, Choi YH et al (2003) NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 112:1383-1394 (Pubitemid 38057692)
14. Bedard K, Krause KH (2007) The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev 87:245-313 (Pubitemid 46209993)
15. BelAiba RS, Djordjevic T, Petry A et al (2007) NOX5 variants are functionally active in endothelial cells. Free Radic Biol Med 42:446-459 (Pubitemid 46162114)
16. Bey E, Xu B, Bhattacharjee A et al (2004) Protein kinase Cd is required for p47phox phosphorylation and translocation in activated human monocytes1. J Immunol 173:5730-5738 (Pubitemid 39392162)
17. Biberstine-Kinkade KJ, DeLeo FR, Epstein RI et al (2001) Hemeligating histidines in flavocytochrome b(558): Identification of specific histidines in gp91(phox). J Biol Chem 276:31105-31112
18. Block ML (2008) NADPH oxidase as a therapeutic target in Alzheimer's disease. BMC Neurosci 9(2):S8
19. Bokoch GM, Prossnitz V (1992) Isoprenoid metabolism is required for stimulation of the respiratory urst oxidase of HL-60 cells. J Clin Invest 89:402-408
20. Bolscher BG, de Boer M, de Klein A et al (1991) Point mutations in the beta-subunit of cytochrome b558 leading to X-linked chronic granulomatous disease. Blood 77:2482-2487
21. Bonnefont-Rousselot D, Raji B, Walrand S et al (2003) An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress. Metabolism 52:586-589 (Pubitemid 36896285)
22. Bouloumie A, Marumo T, Lafontan M et al (1999) Leptin induces oxidative stress in human endothelial cells. FASEBJ 13:1231-1238 (Pubitemid 29300368)
23. Brandes RP, Schröder K (2008) Differential vascular functions of Nox family NADPH oxidases. Curr Opin Lipidol 19:513-518
24. Brandsch R, Bichler V (1987) Covalent flavinylation of 6-hydroxy-Dnicotine oxidase involves an energy-requiring process. FEBS Lett 224:121-124
25. Bromberg Y, Pick E (1985) Activation of NADPH-dependent superoxide production in a cell-free system by sodium dodecyl sulfate. J Biol Chem 260:13539-13545 (Pubitemid 16192304)
26. Cachia O, Benna JE, Pedruzzi E et al (1998) Alpha-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47phox membrane translocation and phosphorylation. J Biol Chem 273:32801-32805 (Pubitemid 28557667)
27. Capone C, Faraco G, Park L et al (2011) The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension. Am J Physiol Heart Circ Physiol 300:H397-H407
28. Cayatte AJ, Rupin A, Oliver-Krasinski J et al (2001) S17834, a new inhibitor of cell adhesion and atherosclerosis that targets NADPH oxidase. Arterioscler Thromb Vasc Biol 21:1577-1584 (Pubitemid 34215575)
29. Cernuda-Morollon E, Ridley AJ (2006) Rho GTPases and leukocyte adhesion receptor expression and function in endothelial cells. Circ Res 98:757-767
30. Chen K, Kirber MT, Xiao H et al (2008) Regulation of ROS signal transduction by NADPH oxidase 4 localization. J Cell Biol 181:1129-1139 (Pubitemid 351915488)
31. Choi SH, Lee DY, Chung ES et al (2005) Inhibition of thrombininduced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo. J Neurochem 95:1755-1765 (Pubitemid 41804071)
32. Ciarcia R, Damiano S, Panico C et al (2010) Apocynin activity in spontaneously hypertensive rats (SHR): Preliminary studies in vivo. Vet Res Commun 34(Suppl 1):S83-S86
33. Clempus RE, Sorescu D, Dikalova AE et al (2007) Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 27:42-48 (Pubitemid 46360379)
34. Coles B, Bloodsworth A, Clark SR et al (2002) Nitrolinoleate inhibits superoxide generation, degranulation, and integrin expression by human neutrophils: Novel antiinflammatory properties of nitric oxide-derived reactive species in vascular cells. Circ Res 91:375-381 (Pubitemid 35034204)
35. Comera C, Andre K, Laffitte J et al (2007) Gliotoxin from Aspergillus fumigatus affects phagocytosis and the organization of the actin cytoskeleton by distinct signalling pathways in human neutrophils. Microbes Infect 9:47-54 (Pubitemid 46157195)
36. Cross AR, Jones OT (1986) The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils. Specific labelling of a component polypeptide of the oxidase. Biochem J 237:111-116 (Pubitemid 16063096)
37. Cross AR, Parkinson JF, Jones OT (1984) The superoxide-generating oxidase of leucocytes. NADPH-dependent reduction of flavin and cytochrome b in solubilized preparations. Biochem J 223:337-344
38. Dahan I, Issaeva I, Gorzalczany Y (2002) Mapping of functional domains in the p22(phox) subunit of flavocytochrome b(559) participating in the assembly of the NADPH oxidase complex by ''peptide walking''. J Biol Chem 277:8421-8432 (Pubitemid 34968303)
39. Dai DZ, Dai Y (2010) Role of endothelin receptor A and NADPH oxidase in vascular abnormalities. Vasc Health Risk Manag 6:787-794
40. Dang PM, Morel F, Gougerot-Pocidalo MA et al (2003) Phosphorylation of the NADPH oxidase component p67(PHOX) by ERK2 and P38MAPK: Selectivity of phosphorylated sites and existence of an intramolecular regulatory domain in the tetratricopeptiderich region. Biochemistry 42:4520-4526 (Pubitemid 36457620)
41. Deby-Dupont G, Mouithys-Mickalad A, Serteyn D et al (2005) Resveratrol and curcumin reduce the respiratory burst of Chlamydia-primed THP-1 ncells. Biochem Biophys Res Commun 333:21-27 (Pubitemid 40813441)
42. DeLeo FR, Yu L, Burritt JB et al (1995) Mapping sites of interaction of p47-phox and flavocytochrome b with random-sequence peptide phage display libraries. Proc Natl Acad Sci USA 92:7110-7114
43. Dewas C, Dang PM, Gougerot-Pocidalo MA et al (2003) TNF-A induces phosphorylation of p47phox in human neutrophils: Partial phosphorylation of p47phox is a common event of priming of human neutrophils by TNF-A and granulocytemacrophage colony-stimulating factor 1. J Immunol 171:4392-4398 (Pubitemid 37238718)
44. Diatchuk V, Lotan O, Koshkin V et al (1997) Inhibition of NADPH oxidase activation by 4-(2-Aminoethyl)-benzenesulfonyl fluoride and related compounds. J Biol Chem 272:13292-13301 (Pubitemid 27216760)
45. Dikalova A, Clempus R, Lassegue B et al (2005) Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 112:2668-2676 (Pubitemid 41532604)
46. Dinauer MC, Pierce EA, Bruns GA et al (1990) Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. Clin Invest 86:1729-1737 (Pubitemid 20372627)
47. Dusting GJ, Selemidis S, Jiang F (2005) Mechanisms for suppressing NADPH oxidase in the vascular wall. Mem Inst Oswaldo Cruz 100(suppl 1):97-103 (Pubitemid 40685446)
48. Dworakowski R, Alom-Ruiz SP, Shah AM (2008) NADPH oxidasederived reactive oxygen species in the regulation of endothelial phenotype. Pharmacol Rep 60:21-28 (Pubitemid 351586539)
49. Egger T, Hammer A, Wintersperger A et al (2001) Modulation of microglial superoxide production by alpha-tocopherol in vitro: Attenuation of p67 (phox) translocation by a protein phosphatasedependent pathway. J Neurochem 79:1169-1182 (Pubitemid 34019795)
50. Ellmark SH, Dusting GJ, Fui MN et al (2005) The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle. Cardiovasc Res 65:495-504 (Pubitemid 40082491)
51. Fan C, Katsuyama M, Nishinaka T et al (2005) Transactivation of the EGF receptor and a PI3 kinase-ATF-1 pathway is involved in the upregulation of NOX1, a catalytic subunit of NADPH oxidase. FEBS Lett 579:1301-1305 (Pubitemid 40248703)
52. Fang J, Lu J, Holmgren A (2005) Thioredoxin reductase is irreversibly modified by curcumin: A novel molecular mechanism for its anticancer activity. J Biol Chem 280:25284-25290 (Pubitemid 40934623)
53. Fernandes DC, Manoel AH, Wosniak J et al (2009) Protein disulfide isomerase overexpression in vascular smooth muscle cells induces spontaneous preemptive NADPH oxidase activation and Nox1 mRNA expression: Effects of nitrosothiol exposure. Arch Biochem Biophys 484:197-204
54. Fontayne A, Dang PM, Gougerot-Pocidalo MA et al (2002) Phosphorylation of p47phox sites by PKC alpha, beta II, delta, and zeta: Effect on binding to p22phox and on NADPH oxidase activation. Biochemistry 41:7743-7750 (Pubitemid 34627801)
55. Francke U, Ochs HD, Darras BT et al (1990) Origin of mutations in two families with X-linked chronic granulomatous disease. Blood 76:602-606 (Pubitemid 20251830)
56. Gatley SJ, Sherratt HS (1976) The effects of diphenyleneiodonium and of 2,4-dichlorodiphenyleneiodonium on mitochondrial reactions. Mechanism of the inhibition of oxygen uptake as a consequence of the catalysis of the chloride/hydroxyl-ion exchange. Biochem J 158:317-326
57. Gayen JR, Zhang K, RamachandraRao SP et al (2010) Role of reactive oxygen species in hyperadrenergic hypertension: biochemical, physiological, and pharmacological evidence from targeted ablation of the chromogranin a (Chga) gene. Circ Cardiovasc Genet 3:414-425
58. Geiszt M (2006) NADPH oxidases: New kids on the block. Cardiovasc Res 71:289-299
59. Geiszt M, Lekstrom K, Witta J et al (2003) Proteins homologous to p47phox and p67phox support superoxide production by NADPH oxidase 1 in colon epithelial cells. J Biol Chem 278:20006-20012 (Pubitemid 36799193)
60. Groemping Y, Rittinger K (2005) Activation and assembly of the NADPH oxidase: A structural perspective. Biochem J 386(3):401-416 (Pubitemid 40445864)
61. Hennig B, Toborek M, McClain CJ et al (1996) Nutritional implications in vascular endothelial cell metabolism. J Am Coll Nutr 15:345-358 (Pubitemid 26264564)
62. Heumüller S, Wind S, Barbosa-Sicard E et al (2008) Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 51:211-217 (Pubitemid 351159930)
63. Holland JA, Meyer JW, Schmitt ME et al (1997) Low-density lipoprotein stimulated peroxide production and endocytosis in cultured human endothelial cells: mechanisms of action. Endothelium 5:191-207 (Pubitemid 27390278)
64. Holland JA, Meyer JW, Chang MM et al (1998) Thrombin stimulated reactive oxygen species production in cultured human endothelial cells. Endothelium 6:113-121 (Pubitemid 128537713)
65. Hu Q, Zheng G, Zweier JL et al (2000) NADPH oxidase activation increases the sensitivity of intracellular Ca2?stores to inositol 1,4,5-trisphosphate in human endothelial cells. J Biol Chem 275:15749-15757 (Pubitemid 30366873)
66. Huang A, Yan C, Suematsu N et al (2010) Impaired flow-induced dilation of coronary arterioles of dogs fed a low-salt diet: roles of ANG II, PKC and NADPH oxidase. Am J Physiol Heart Circ Physiol 299:H1476-H1483
67. Hutchinson DS, Csikasz RI, Yamamoto DL et al (2007) Diphenylene iodonium stimulates glucose uptake in skeletal muscle cells through mitochondrial complex I inhibition and activation of AMPactivated protein kinase. Cell Signal 19:1610-1620 (Pubitemid 46818924)
68. Ibi M, Matsuno K, Shiba D et al (2008) Reactive oxygen species derived from NOX1/NADPH oxidase enhance inflammatory pain. J Neurosci 28:9486-9494
69. Inoue N, Ohara Y, Fukai T et al (1998) Probucol improves endothelial-dependent relaxation and decreases vascularsuperoxide production in cholesterol-fed rabbits. Am J Med Sci 315:242-247 (Pubitemid 28207657)
70. Ippoushi K, Itou H, Azuma K et al (2002) Effect of naturally occurring organosulfur compounds on nitric oxide production in lipopolysaccharideactivated macrophages. Life Sci 71:411-419 (Pubitemid 34614543)
71. Itoh H, Komori K, Okazaki Je et al (1997) The effect of probucol on intimal thickening of autologous vein grafts in hyperlipidemic rabbit. Cardiovasc Surg 5:497-503 (Pubitemid 27461440)
72. Itoh S, Umemoto S, Hiromoto M et al (2002) Importance of NADPH oxidase-mediated oxidative stress and contractile type smooth muscle myosin heavy chain SM2 at the early stage of atherosclerosis. Circulation 105:2288-2295 (Pubitemid 34535340)
73. Jagnandan D, Church JE, Banfi B et al (2007) Novel mechanism of activation of NADPH oxidase 5. calcium sensitization via phosphorylation. J Biol Chem 282:6494-6507 (Pubitemid 47100887)
74. Johnson DK, Schillinger KJ, Kwait DM et al (2002) Inhibition of NADPH oxidase activation in endothelial cells by orthomethoxysubstituted catechols. Endothelium 9:191-203 (Pubitemid 35021589)
75. Jones S, Howl J (2006) Biological applications of the receptor mimetic peptide mastoparan. Curr Protein Pept Sci 7:501-508 (Pubitemid 44883927)
76. Judkins CP, Diep H, Broughton BR et al (2010) Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/-mice. Am J Physiol Heart Circ Physiol 298:H24-H32
77. Kahles T, Luedike P, Endres M et al (2007) NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke 38:3000-3006 (Pubitemid 350035696)
78. Kalinowski L, Malinski T (2004) Endothelial NADH/NADPH-dependent enzymatic sources of superoxide production: relationship to endothelial dysfunction. Acta Biochim Pol 51:459-469 (Pubitemid 38969307)
79. Kaneyuki U, Ueda S, Yamagishi S et al (2007) Pitavastatin inhibits lysophosphatidic acid-induced proliferation and monocyte chemoattractant protein-1 expression in aortic smooth muscle cells by suppressing Rac-1-mediated reactive oxygen species generation. Vascul Pharmacol 46:286-292 (Pubitemid 46124092)
80. Kanno T, Utsumi T, Takehara Y et al (1996) Inhibition of neutrophilsuperoxide generation by alpha-tocopherol and coenzyme Q. Free Radic Res 24:281-289 (Pubitemid 26144651)
81. Kawahara T, Lambeth JD (2007) Molecular evolution of Phox-related regulatory subunits for NADPH oxidase enzymes. BMC Evol Biol 7:178
82. Kawahara T, Kuwano Y, Teshima-Kondo S et al (2004) Role of nicotinamide adenine dinucleotide phosphate oxidase 1 in oxidative burst response to Toll-like receptor 5 signaling in large intestinal epithelial cells. J Immunol 172:3051-3058 (Pubitemid 38263694)
83. Kawahara T, Ritsick D, Cheng G et al (2005) Point mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1-And Nox2-dependent reactive oxygen generation. J Biol Chem 280:31859-31869 (Pubitemid 41291936)
84. Kawczynska-Drozdz A, Olszanecki R, Jawien J et al (2006) Ghrelin inhibits vascular superoxide production in spontaneously hypertensive rats. Am J Hypertens 19:764-767 (Pubitemid 43928520)
85. Keaney JF Jr, Xu A, Cunningham D et al (1995) Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest 95:2520-2529
86. Kennedy JA, Beck-Oldach K, McFadden-Lewis K et al (2006) Effect of the anti-Anginal agent, perhexiline, on neutrophil, valvular and vascular superoxide formation. Eur J Pharmacol 531:13-19 (Pubitemid 43202209)
87. Kikuchi H, Hikage M, Miyashita H et al (2000) NADPH oxidase subunit, gp91(phox) homologue, preferentially expressed in human colon epithelial cells. Gene 254:237-243
88. Kim C, Park E, Quinn MR et al (1996) The production of superoxide anion and nitric oxide by cultured murine leukocytes and the accumulation of TNFalpha in the conditioned media is inhibited by taurine chloramine. Immunopharmacology 34:89-95 (Pubitemid 26290386)
89. Koga H, Terasawa H, Nunoi H et al (1999) Tetratricopeptide repeat (TPR) motifs of p67(phox) participate in interaction with the small GTPase Rac and activation of the phagocyte NADPH oxidase. J Biol Chem 274:25051-25060
90. Kou B, Zhang J, Singer DR (2009) Effects of cyclic strain on endothelial cell apoptosis and tubulogenesis are dependent on ROS production via NADPH subunit p22phox. Microvasc Res 77:125-133
91. Koupparis AJ, Jeremy JY, Muzaffar S et al (2005) Sildenafil inhibits the formation of superoxide and the expression of gp47phox NADPH oxidase induced by the thromboxane A2 mimetic, U46619, in corpus cavernosal smooth muscle cells. BJU Int 96:423-427 (Pubitemid 41097694)
92. Krötz F, Keller M, Derflinger S et al (2007) Mycophenolate acid inhibits endothelial NADPH oxidase activity and superoxide formation by a Rac1-dependent mechanism. Hypertension 49:201-208 (Pubitemid 46360361)
93. Kwak JY, Takeshige K, Cheung BS et al (1991) Bilirubin inhibits the activation of superoxide-producing NADPH oxidase in a neutrophil cell-free system. Biochim Biophys Acta 1076:369-373
94. Kweon YO, Paik YH, Schnabl B et al (2003) Gliotoxin-mediated apoptosis of activated human hepatic stellate cells. J Hepatol 39:38-46 (Pubitemid 36724106)
95. Lafeber FP, Beukelman CJ, van den Worm E et al (1999) Apocynin, a plant-derived, cartilage-saving drug, might be useful in the treatment of rheumatoid arthritis. Rheumatology 38:1088-1093 (Pubitemid 29537328)
96. Landmesser U, Harrison DG (2001) Oxidative stress and vascular damage in hypertension. Coron Artery Dis 12:455-461 (Pubitemid 32977815)
97. 2 expression via inhibition of NADPH oxidase: Implications for protection against endotoxic shock in rats. FASEB J 19:1890-1892 (Pubitemid 41598785)
98. Lapouge K, Smith SJ, GroempingY et al (2002)Architecture of the p40-p47-p67phox complex in the resting state of theNADPHoxidase.A central role for p67phox. J Biol Chem 277:10121-10128 (Pubitemid 34968123)
99. Lassegue B, Clempus RE (2003) Vascular NADPH oxidases: Specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285:277-297
100. Lee NK, Choi YG, Baik JY et al (2005) A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106:852-859 (Pubitemid 41076424)
101. Lee YW, Lee WH, Kim PH (2010) Role of NADPH oxidase in interleukin-4-induced monocyte chemoattractant protein-1 expression in vascular endothelium. Inflamm Res 59:755-765
102. Leiro J, Alvarez E, Arranz JA et al (2004) Effects of cisresveratrol on inflammatory murine macrophages: Antioxidant activity and downregulation of inflammatory genes. J Leukoc Biol 75:1156-1165 (Pubitemid 38720660)
103. Leusen JHW, Verhoeven AJ, Roos D (1996) Interactions between the components of the human NADPH oxidase: A review about the intrigues in the phox family. Front Biosci 1:d72-d90
104. Li JM, Shah AM (2003) Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit. J Biol Chem 278:12094-12100 (Pubitemid 36800187)
105. Li L, Fink GD, Watts SW et al (2003) Endothelin-1 increases vascular superoxide via endothelinA-NADPH oxidase pathway in lowrenin hypertension. Circulation 107:1053-1058 (Pubitemid 36258731)
106. Li JM, Fan LM, Christie MR et al (2005) Acute tumor necrosis factor alpha signaling via NADPH oxidase in microvascular endothelial cells: role of p47phox phosphorylation and binding to TRAF4. Mol Cell Biol 25:2320-2330 (Pubitemid 40354628)
107. 2 -dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes. Mol Cell Biol 26:140-154
108. Li Y, Le'vesque LO, Anand-Srivastava MB (2010) Epidermal growth factor receptor transactivation by endogenous vasoactivepeptides contributes to hyperproliferation of vascular smooth muscle cells of SHR. Am J Physiol Heart Circ Physiol 299:H1959-H1967
109. Lima ES, Bonini MG, Augusto O et al (2005) Nitrated lipids decompose to nitric oxide and lipid radicals and cause vasorelaxation. Free Radic Biol Med 39:532-539 (Pubitemid 41021651)
110. Lyle AN, Deshpande NN, Taniyama Y et al (2009) Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res 105:249-259
111. Mahrouf M, Ouslimani N, Peynet J et al (2006) Metformin reduces angiotensin-mediated intracellular production of reactive oxygen species in endothelial cells through the inhibition of protein kinase C. Biochem Pharmacol 72:176-183 (Pubitemid 43850435)
112. Marco G, Michele S (2007) The role of PDE5-inhibitors in cardiopulmonary disorders: from basic evidence to clinical development. Curr Med Chem 14:2181-2192
113. Martyn KD, Frederick LM, von Loehneysen K (2006) Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal 18:69-82 (Pubitemid 41415716)
114. Mason RP, Kalinowski L, Jacob RF et al (2005) Nebivolol reduces nitroxidative stress and restores nitric oxide bioavailability in endothelium of Black Americans. Circulation 112:3795-3801 (Pubitemid 43739521)
115. Miller AA, Drummond GR, Sobey CG (2006) Novel isoforms of NADPH-oxidase in cerebral vascular control. Pharmacol Ther 111:928-948 (Pubitemid 44160524)
116. Miller SJ, Coppinger BJ, Zhou X et al (2010) Antioxidants reverse age-related collateral growth impairment. J Vasc Res 47:108-114
117. Miyoshi N, Takabayashi S, Osawa T et al (2004) Benzyl isothiocyanate inhibits excessive superoxide generation in inflammatory leukocytes: Implication for prevention against inflammationrelated carcinogenesis. Carcinogenesis 25:567-575 (Pubitemid 38499945)
118. Modlinger P, Chabrashvili T, Gill PS et al (2006) RNA silencing in vivo reveals role of p22phox in rat angiotensin slow pressor response. Hypertension 47:238-244 (Pubitemid 43189769)
119. Mollnau H, Schulz E, Daiber A et al (2003) Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells. Arterioscler Thromb Vasc Biol 23:615-621 (Pubitemid 36438074)
120. Montezano AC, Burger D, Ceravolo GS et al (2011) Novel Nox homologues in the vasculature: focusing on Nox4 and Nox5. Clin Sci 120:131-141
121. Muzaffar S, Shukla N, Srivastava A et al (2005) Sildenafil citrate and sildenafil nitrate (NCX 911) are potent inhibitors of superoxide formation and gp91phox expression in porcine pulmonary artery endothelial cells. Br J Pharmacol 146:109-117 (Pubitemid 43086100)
122. Nisimoto Y, Tsubouchi R, Diebold BA et al (2008) Activation of NADPH oxidase 1 in tumour colon epithelial cells. Biochem J 415:57-65
123. O'Donnell BV, Tew DG, Jones OT et al (1993) Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. Biochem J 290(Pt 1):41-49 (Pubitemid 23081198)
124. O'Donnell VB, Smith GC, Jones OT (1994) Involvement of phenyl radicals in iodonium inhibition of flavoenzymes. Mol Pharmacol 46:778-785
125. Oelze M, Daiber A, Brandes RP et al (2006) Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats. Hypertension 48:677-684 (Pubitemid 44843872)
126. Ouslimani N, Peynet J, Bonnefont-Rousselot D et al (2005) Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells. Metabolism 54:829-834 (Pubitemid 40725333)
127. Ozaki Y, Ohashi T, Niwa Y (1986) A comparative study on the effects of inhibitors of the lipoxygenase pathway on neutrophil function. Inhibitory effects on neutrophil function may not be attributed to inhibition of the lipoxygenase pathway. Biochem Pharmacol 35:3481-3488 (Pubitemid 17179190)
128. Panico C, Luo Z, Damiano S et al (2009) Renal proximal tubular reabsorption is reduced in adult spontaneously hypertensive rats: roles of superoxide and Na?/H?exchanger 3. Hypertension 54:1291-1297
129. Park YM, Park MY, Suh YL et al (2004) NADPH oxidase inhibitor prevents blood pressure elevation and cardiovascular hypertrophy in aldosterone-infused rats. Biochem Biophys Res Commun 313:812-817 (Pubitemid 38021903)
130. Perry DK, Hand WL, Edmondson DE et al (1992) Role of phospholipase D-derived diradylglycerol in the activation of the human neutrophil respiratory burst oxidase. Inhibition by phosphatidic acid phosphohydrolase inhibitors. J Immunol 149:2749-2758
131. Petry A, Djordjevic T, Weitnauer M et al (2006) NOX2 and NOX4 mediate proliferative response in endothelial cells. Antioxid Redox Signal 8:1473-1484 (Pubitemid 44726324)
132. Pflueger A, Croatt AJ, Peterson TE et al (2005) The hyperbilirubinemic Gunn rat is resistant to the pressor effects of angiotensin II. Am J Physiol Renal Physiol 288:F552-F558 (Pubitemid 40279462)
133. Poolman TM, Ng LL, Farmer PB et al (2005) Inhibition of the respiratory burst by resveratrol in human monocytes: correlation with inhibition of PI3K signaling. Free Radic Biol Med 39:118-132 (Pubitemid 40733122)
134. Quinn MT, Ammons MC, Deleo FR (2006) The expanding role of NADPH oxidases in health and disease: No longer just agents of death and destruction. Clin Sci 111:1-20 (Pubitemid 44023407)
135. Raad H, Paclet MH, Boussetta T et al (2009) Regulation of the phagocyte NADPH oxidase activity: Phosphorylation of gp91phox/NOX2 by protein kinase C enhances its diaphorase activity and binding to Rac2, p67phox, and p47phox. FASEB J 23:1011-1022
136. Rajagopalan S, Kurz S, Munzel T et al (1996) Angiotensin IImediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97:1916-1923
137. Ray R, Shah AM (2005) NADPH oxidase and endothelial cell function. Clin Sci 109:217-226 (Pubitemid 41337126)
138. Rey FE, Cifuentes ME, Kiarash A et al (2001) Novel competitive inhibitor of NADPH oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ Res 89:408-414 (Pubitemid 34132656)
139. Riganti C, Gazzano E, Polimeni M et al (2004) Diphenyleneiodonium inhibits the cell redox metabolism and induces oxidative stress. J Biol Chem 279:47726-47731 (Pubitemid 39540920)
140. Rossary A, Arab K, Steghens JP (2007) Polyunsaturated fatty acids modulate NOX 4 anion superoxide production in human fibroblasts. Biochem J 406:77-83 (Pubitemid 47264737)
141. Rossi F, Zatti M (1964) Biochemical aspects of phagocytosis in polymorphonuclear leucocytes. NADH and NADPH oxidation by the granules of resting and phagocytizing cells. Experientia 20:21-23
142. Rueckschloss U, Galle J, Holtz J et al (2001) Induction of NADPH oxidase by oxidized low-density lipoprotein in human endothelial cells: Antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy. Circulation 104:1767-1772 (Pubitemid 32963340)
143. Schubert ML (2007) Gastric secretion. Curr Opin Gastroenterol 23:595-601 (Pubitemid 47508787)
144. Schulz E, Münzel T (2008) NOX5, a new ''radical'' player in human atherosclerosis? J Am Coll Cardiol 52:1803-1809
145. Sedeek M, Hébert RL, Kennedy CR et al (2009) Molecular mechanisms of hypertension: role of Nox family NADPH oxidases. Curr Opin Nephrol Hypertens 18:122-127
146. Sehr P, Joseph G, Genth H et al (1998) Glucosylation and ADP ribosylation
147. Selemidis S, Sobey CG, Wingler K et al (2008) NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. Pharmacol Ther 120:254-291
148. Serrander L, Cartier L, Bedard K et al (2007) NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J 406:105-114 (Pubitemid 47264740)
149. Shi J, Ross CR, Leto TL et al (1996) PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47phox. Proc Natl Acad Sci USA 93:6014-6018
150. Shukla N, Jones R, Persad R et al (2005) Effect of sildenafil citrate and a nitric oxide donating sildenafil derivative, NCX 911, on cavernosal relaxation and superoxide formation in hypercholesterolaemic rabbits. Eur J Pharmacol 517:224-231 (Pubitemid 40977899)
151. Si J, Fu X, Behar J et al (2007) NADPH oxidase NOX5-S mediates acid-induced cyclooxygenase-2 expression via activation of NFkappaB in Barrett's esophageal adenocarcinoma cells. J Biol Chem 282:16244-16255 (Pubitemid 47100387)
152. Simons JM, Hart LA, van Dijk H et al (1989) Immunodulatory compounds from Picrorhiza kurroa: Isolation and characterization of two anti-complementary polymeric fractions from an aqueous root extract. J Ethnopharmacol 26:169-182 (Pubitemid 19257819)
153. Sorescu D, Weiss D, Lassegue B et al (2002) Superoxide production and expression of Nox family proteins in human atherosclerosis. Circulation 105:1429-1435 (Pubitemid 34263273)
154. Stefanska J, Pawliczak R (2008) Apocynin: molecular aptitudes. Mediat Inflamm 2008:106507
155. Stielow C, Catar RA, Muller G et al (2006) Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells. Biochem Biophys Res Commun 344:200-205
156. Stocker R, Keaney JF Jr (2004) Role of oxidative modifications in atherosclerosis. Physiol Rev 84:1381-1478 (Pubitemid 39302636)
157. Stolk J, Hiltermann TJ, Dijkman JH et al (1994) Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxysubstituted catechol. Am J Respir Cell Mol Biol 11:95-102
158. Stuehr DJ, Fasehun OA, Kwon NS et al (1991) Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J 5:98-103 (Pubitemid 21892842)
159. Suh YA, Arnold RS, Lassegue B et al (1999) Cell transformation by the superoxide-generating oxidase Mox1. Nature 401:79-82
160. Sun Y, Asnicar M, Smith RG (2007) Central and peripheral roles of ghrelin on glucose homeostasis. Neuroendocrinology 86:215-228 (Pubitemid 350073609)
161. Szanto I, Rubbia-Brandt L, Kiss P et al (2005) Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease. J Pathol 207:164-176 (Pubitemid 41404147)
162. Hart BA, Simons JM, Knaan-Shanzer S et al (1990) Antiarthritic activity of the newly developed neutrophil oxidative burst antagonist apocynin. Free Radic Biol Med 9:127-131
163. Takai S, Jin D, Shimosato T et al (2011) Candesartan and amlodipine combination therapy provides powerful vascular protection in stroke-prone spontaneously hypertensive rats. Hypertens Res 34:245-252
164. Takeya R, Sumimoto H (2006) Regulation of novel superoxideproducing NADPH oxidases. Antioxid Redox Signal 8:1523-1532 (Pubitemid 44726328)
165. 2 870 attenuates PDGF-dependent smoothmuscle cell chemotaxis, but not proliferation. Cardiovasc Res 71:331-341
166. Tisch D, Sharoni Y, Danilenko M (1995) The assembly of neutrophil NADPH oxidase: Effects of mastoparan and its synthetic analogues. Biochem J 310(Pt 2):715-719
167. Tisch-Idelson D, Fridkin M, Wientjes F et al (2001) Structurefunction relationship in the interaction of mastoparan analogs with neutrophil NADPH oxidase. Biochem Pharmacol 61:1063-1071 (Pubitemid 32285473)
168. Touyz RM, Briones AM (2011) Reactive oxygen species and vascular biology: Implications in human hypertension. Hypertens Res 34:5-14
169. Touyz RM, Schiffrin EL (2004) Reactive oxygen species in vascular biology: Implications in hypertension. Histochem Cell Biol 122:339-352 (Pubitemid 39506592)
170. Troost R, Schwedhelm E, Rojczyk S et al (2000) Nebivolol decreases systemic oxidative stress in healthy volunteers. Br J Clin Pharmacol 50:377-379
171. Tsai MH, Jiang MJ (2010) Reactive oxygen species are involved in regulating alpha1-Adrenoceptor-Activated vascular smooth muscle contraction. J Biomed Sci 17:67
172. Tsunawaki S, Nathan CF (1986) Release of arachidonate and reduction of oxygen. Independent metabolic bursts of the mouse peritoneal macrophage. J Biol Chem 261:11563-11570 (Pubitemid 17206073)
173. Tsunawaki S, Yoshida LS, Nishida S et al (2004) Fungal metabolite gliotoxin inhibits assembly of the human respiratory burst NADPH oxidase. Infect Immun 72:3373-3382 (Pubitemid 38697762)
174. Vejrazka M, Mícek R, Stípek S (2005) Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS production in nonphagocytic cells. Biochim Biophys Acta 1722:143-147 (Pubitemid 40299004)
175. Vendrov AE, Hakim ZS, Madamanchi NR et al (2007) Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells. Arterioscler Thromb Vasc Biol 27:2714-2721 (Pubitemid 350158927)
176. Vendrov AE, Madamanchi NR, Niu XL et al (2010) NADPH oxidases regulate CD44 and hyaluronic acid expression in thrombintreated vascular smooth muscle cells and in atherosclerosis. J Biol Chem 285:26545-26557
177. Venugopal SK, Devaraj S, Yang T et al (2002) Alpha-Tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-Alpha. Diabetes 51:3049-3054
178. Vignais PV (2002) The superoxide-generating NADPH oxidase: Structural aspects and activation mechanism. Cell Mol Life Sci 59:1428-1459 (Pubitemid 35239301)
179. Violi F, Sanguigni V, Carnevale R et al (2009) Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study. Circulation 120:1616-1622
180. Walch L, Massade L, Dufilho M et al (2006) Pro-Atherogenic effect of interleukin-4 in endothelial cells: modulation of oxidative stress, nitric oxide and monocyte chemoattractant protein-1 expression. Atherosclerosis 187:285-291 (Pubitemid 43963018)
181. Wallach TM, Segal AW (1997) Analysis of glycosylation sites on gp91phox, the flavocytochrome of the NADPH oxidase, by sitedirected mutagenesis and translation in vitro. Biochem J 321(3):583-585
182. Wassmann S, Laufs U, Muller K et al (2002) Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol 22:300-305 (Pubitemid 34127043)
183. Williams HC, Griendling KK (2007) NADPH Oxidase inhibitors: New antihypertensive agents? J Cardiovasc Pharmacol 50:9-16 (Pubitemid 47220441)
184. Wind S, Beuerlein K, Armitage ME et al (2010) Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1/2 is reversed by NADPH oxidase inhibition. Hypertension 56:490-497
185. Xaplanteris P, Vlachopoulos C, Baou K et al (2010) The effect of p22(phox) -930A/G, A640G and C242T polymorphisms ofNADPH oxidase on peripheral and central pressures in healthy, normotensive individuals. Hypertens Res 33:814-818
186. Xiao D, Vogel V, Singh SV (2006) Benzyl isothiocyanate-induced apoptosis in human breast cancer cells is initiated by reactive oxygen species and regulated by Bax and Bak. Mol Cancer Ther 5:2931-2945 (Pubitemid 44849021)
187. Ximenes VF, Kanegae MP, Rissato SR et al (2007) The oxidation of apocynin catalyzed by myeloperoxidase: Proposal for NADPH oxidase inhibition. Arch Biochem Biophys 457:134-141 (Pubitemid 46048700)
188. Xue B, Beltz TG, Yu Y et al (2011) Central Interactions of Aldosterone (Aldo) and Angiotensin II (ANG II) in Aldo-And ANG II-induced Hypertension. Am J Physiol Heart Circ Physiol 300:H555-H564
189. Yang M, Foster E, Kahn AM (2005) Insulin-stimulated NADPH oxidase activity increases migration of cultured vascular smooth muscle cells. Am J Hypertens 18:1329-1334 (Pubitemid 41400203)
190. Yibin G, Jiang Z, Hong Z et al (2005) A synthesized cationic tetradecapeptide from hornet venom kills bacteria and neutralizes lipopolysaccharide in vivo and in vitro. Biochem Pharmacol 70:209-219 (Pubitemid 40814403)
191. Yoshida LS, Abe S, Tsunawaki S (2000) Fungal gliotoxin targets the onset of superoxide-generating NADPH oxidase of human neutrophils. Biochem Biophys Res Commun 268:716-723 (Pubitemid 30150857)
192. Zang M, Xu S, Maitland-Toolan KA et al (2006) Polyphenols stimulate AMP-Activated protein kinase, lower lipids and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 55:2180-2191 (Pubitemid 44743614)
193. Zhan S, Vazquez N, Zhan S et al (1996) Genomic structure, chromosomal localization, start of transcription, and tissue expression of the human p40-phox, a new component of the nicotinamide adenine dinucleotide phosphate-oxidase complex. Blood 88:2714-2721 (Pubitemid 26327525)
194. Zhang Y, Chan MM, Andrews MC et al (2005) Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormoneinduced hypertension in the rat. Am J Hypertens 18:910-916 (Pubitemid 41040260)
195. Zhu Y, Marchal CC, Casbon AJ et al (2006) Deletion mutagenesis of p22phox subunit of flavocytochrome b558: Identification of regions critical for gp91phox maturation and NADPH oxidase activity. J Biol Chem 281:30336-30346 (Pubitemid 44582087)